Lacy Hubbard, President and CEO of Elekta Foundation, shared on LinkedIn:
“Yesterday, New York City wasn’t showing her best weather and traffic was wild during UNGA, but the Bloomberg building was packed with enthusiastic Ministries of Health, investors, and global leaders in cancer care. Everyone was excited to be part of the Global Cancer Platform launch, a powerful step toward transforming cancer equity.
Focused on action, the platform aims to mobilize $1B by 2030 to expand access to early detection and treatment in low- and middle-income countries and starts with two leading causes of cancer death among women – cervical and breast cancer. It also supports diagnostic infrastructure, workforce training, and treatment capacity, helping countries build resilient and equitable cancer care systems.
As someone deeply involved in implementing cervical and breast cancer screening programs in low-income countries, I see firsthand why this matters. Cancer is becoming a silent pandemic that won’t end. By 2040, we will see 25% more new cases globally. We must act now and act fast. The Elekta Foundation stands ready to collaborate with partners and countries to strengthen early detection, expand access to care, and scale what works.
We need the urgency of this moment, and we need innovative financing to match new technologies and operational excellence. Thank you to the Bloomberg New Economy International Cancer Coalition, ASCO, and a special shout-out to Dr. Catharine Young, Ph.D. for her incredible dedication in bringing this convening to life. Seeing so many familiar faces in New York, all driven by the same purpose, was an absolute bonus.”
More from Lacy Hubbard on OncoDaily.
